Plasmodium ovale: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox disease | |||
| name = Plasmodium ovale | |||
| image = <!-- Image removed --> | |||
| caption = <!-- Image caption removed --> | |||
| field = Infectious disease | |||
| symptoms = Fever, chills, headache, muscle pain | |||
| complications = Anemia, splenomegaly | |||
| duration = Weeks to months | |||
| causes = [[Plasmodium ovale]] infection | |||
| risks = [[Mosquito]] bites, travel to endemic areas | |||
| diagnosis = [[Blood smear]], [[PCR]] | |||
| treatment = [[Antimalarial medication]] | |||
| prevention = [[Mosquito control]], [[prophylactic medication]] | |||
}} | |||
'''Plasmodium ovale''' is a [[protozoan]] [[parasite]] and one of the species of [[Plasmodium]] that cause [[malaria]] in humans. It is less common than [[Plasmodium falciparum]] and [[Plasmodium vivax]], and is primarily found in [[West Africa]], although it has also been reported in [[Southeast Asia]] and [[South America]]. | |||
Plasmodium ovale | |||
==Life Cycle== | == Life Cycle == | ||
The life cycle of Plasmodium ovale | The life cycle of ''Plasmodium ovale'' involves two hosts: the [[Anopheles mosquito]] and humans. The [[sporozoite]] form of the parasite is transmitted to humans through the bite of an infected mosquito. Once in the human host, the sporozoites travel to the [[liver]], where they mature into [[schizonts]], which then release [[merozoites]] into the bloodstream. These merozoites infect [[red blood cells]], leading to the clinical symptoms of malaria. | ||
== | == Clinical Features == | ||
Infection with ''Plasmodium ovale'' typically results in a milder form of malaria compared to ''P. falciparum''. Symptoms include [[fever]], [[chills]], [[headache]], and [[muscle pain]]. The fever pattern is often tertian, occurring every 48 hours. Complications are rare but can include [[anemia]] and [[splenomegaly]]. | |||
== | == Diagnosis == | ||
Diagnosis of ''Plasmodium ovale'' infection is primarily through microscopic examination of a [[blood smear]], where the characteristic oval-shaped [[trophozoites]] and [[schizonts]] can be identified. [[Polymerase chain reaction]] (PCR) tests can also be used for more accurate identification. | |||
== | == Treatment == | ||
Plasmodium ovale malaria is | The treatment for ''Plasmodium ovale'' malaria involves the use of [[antimalarial drugs]] such as [[chloroquine]] and [[primaquine]]. Primaquine is particularly important for eradicating the [[hypnozoite]] stage in the liver, which can cause relapses if not treated. | ||
== Prevention == | |||
Preventive measures include [[mosquito control]] strategies such as the use of [[insecticide-treated bed nets]] and [[indoor residual spraying]]. Travelers to endemic areas may also take [[prophylactic medication]] to reduce the risk of infection. | |||
== | == See Also == | ||
* [[Malaria]] | * [[Malaria]] | ||
* [[Plasmodium falciparum]] | * [[Plasmodium falciparum]] | ||
* [[Plasmodium vivax]] | * [[Plasmodium vivax]] | ||
* [[Anopheles | * [[Anopheles mosquito]] | ||
== References == | |||
{{ | {{Reflist}} | ||
[[Category: | == External Links == | ||
* [https://www.cdc.gov/malaria/ CDC Malaria] | |||
* [https://www.who.int/malaria/en/ WHO Malaria] | |||
[[Category:Malaria]] | |||
[[Category:Parasitic diseases]] | [[Category:Parasitic diseases]] | ||
[[Category: | [[Category:Protozoal diseases]] | ||
[[Category:Tropical diseases]] | |||
Revision as of 17:07, 29 December 2024
| Plasmodium ovale | |
|---|---|
| ICD-10 | |
| ICD-9 | |
| DiseasesDB | |
| MedlinePlus | |
| eMedicine | |
| MeSH ID | |
Plasmodium ovale is a protozoan parasite and one of the species of Plasmodium that cause malaria in humans. It is less common than Plasmodium falciparum and Plasmodium vivax, and is primarily found in West Africa, although it has also been reported in Southeast Asia and South America.
Life Cycle
The life cycle of Plasmodium ovale involves two hosts: the Anopheles mosquito and humans. The sporozoite form of the parasite is transmitted to humans through the bite of an infected mosquito. Once in the human host, the sporozoites travel to the liver, where they mature into schizonts, which then release merozoites into the bloodstream. These merozoites infect red blood cells, leading to the clinical symptoms of malaria.
Clinical Features
Infection with Plasmodium ovale typically results in a milder form of malaria compared to P. falciparum. Symptoms include fever, chills, headache, and muscle pain. The fever pattern is often tertian, occurring every 48 hours. Complications are rare but can include anemia and splenomegaly.
Diagnosis
Diagnosis of Plasmodium ovale infection is primarily through microscopic examination of a blood smear, where the characteristic oval-shaped trophozoites and schizonts can be identified. Polymerase chain reaction (PCR) tests can also be used for more accurate identification.
Treatment
The treatment for Plasmodium ovale malaria involves the use of antimalarial drugs such as chloroquine and primaquine. Primaquine is particularly important for eradicating the hypnozoite stage in the liver, which can cause relapses if not treated.
Prevention
Preventive measures include mosquito control strategies such as the use of insecticide-treated bed nets and indoor residual spraying. Travelers to endemic areas may also take prophylactic medication to reduce the risk of infection.
See Also
References
<references group="" responsive="1"></references>